المؤلفون: National Institute of Hygiene and Epidemiology, Vietnam, ANRS, Emerging Infectious Diseases

المصدر: Tran TH, Nguyen BT, Nguyen TA, Pham TTP, Nguyen TTT, MaHTB, Pham HB, Nguyen TM, Phan HTT, Do NT, A-Ahmed M, Tab F, Madec Y. Drd blood spots perform well to enty patnts wh acte HCV fectn Vtnam. J Val Hepat. 2020 May;27(5):514-519. do 10.1111/jvh.13263. Epub 2020 Feb 11.
Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05506475Test

المؤلفون: National Cancer Institute (NCI)

المصدر: Investigating Human Papillomavirus (HPV) Infection and HPV-Associated Disease in Indian Men Who Have Sex With Men Who Are HIV-Positive

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04142398Test

المؤلفون: AbbVie, National Institute of Allergy and Infectious Diseases (NIAID)

المصدر: Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04042740Test

المصدر: Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03941210Test

المصدر: Open-Label Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of Topical Abi-1968 In Subjects With Anal High-Grade Squamous Intraepithelial Lesions (aHSIL)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03677960Test

المؤلفون: National Cancer Institute (NCI), University of Arkansas, AIDS and Cancer Specimen Resource, Merck Sharp & Dohme LLC, The Emmes Company, LLC, University of California, Los Angeles

المصدر: A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions Among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03284866Test

المصدر: Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Topical ABI-1968 in Subjects With Anal High-Grade Squamous Intraepithelial Lesions (aHSIL)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03202992Test

المؤلفون: National Cancer Institute (NCI), National Institutes of Health (NIH)

المصدر: Improving Screening Tools to Better Predict High-Grade Anal Dysplasia for MSM

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02816879Test

المصدر: Neva FA. Blogy and munology of human strongylos. J fect D. 1986 Mar;153(3):397-406. do 10.1093/fd/153.3.397.
Newton RC, Lpuangth P, Greenberg S, Gam A, Neva FA. Strongyloes stercoral hyperfectn a carrr of HTLV-vus wh evence of selecte munosuppressn. Am J Med. 1992 Feb;92(2):202-8. do 10.1016/0002-9343(92)90113-p.
Sato Y, Otsuru M, Takara M, Shoma Y. tradermal reactns strongylos. t J Parasol. 1986 Feb;16(1):87-91. do 10.1016/0020-7519(86)90070-6. No abstract avaable.
Study of Patients With Known or Suspected Infection With Strongyloides Stercoralis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00001245Test

Other URLs: http://clinicalstudies.info.nih.gov/detail/B_1989-I-0174.htmlTest

المصدر: EFFICACY AND SAFETY OF A ONCE DAILY FIXED-DOSE COMBINATION OF ABACAVIR/LAMIVUDINE (ABC/3TC) [FDC ] VERSUS ABC TWICE DAILY AND 3TC ONCE DAILY AS SEPARATE ENTITIES [SE] IN ART-EXPERIENCED HIV-1 INFECTED SUBJECTS (CAL30001): 48 WEEK DATA. Clumeck, N., LaMarca, A., Fu, K., Gordon, D., Craig, C., Zhao, H. , Paes, D., and Scott, T. (WePe6.3C13), 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro; Brazil, 7/24/2005
C Craig, C Stone, T Bonny, K Fu. Similar virology findings in ABC/3TC fixed dose combination (FDC) OAD compared with standard dosing in experienced subjects (CAL30001, ALTO). 7th ICDTHI, Glasgow, UK, 14-18 November 2004. Abstract 98
Clumeck N, Lamarca A, Fu K, Gordon D, Craig C, Zhao H, Paes D, Scott T. Safety and efficacy of a once daily (OAD) Fixed-Dose Combination (FDC) of ABC/3TC [FDC arm] versus ABC twice daily (BID) and 3TC OAD as separate entities [SE arm] in ART-Experienced HIV-1 Infected Patients. 44th ICAAC, Washington, DC, 30 October-2 November 2004. Abstr. H-558
See Detailed Description

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00044577Test